INNATE PHARMA (EPA:IPH) | WebDisclosure

PRESS RELEASE

published on 09/02/2025 at 07:00, 10 months 12 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Innate Pharma releases the total number of shares (92,185,473 ordinary shares, 6,419 Preferred Shares 2016, 7,581 Preferred Shares 2017) and voting rights (92,962,943 theoretical, 92,944,368 exercisable) as of September 1, 2025 in compliance with regulations

Voting Rights Shares Stock Market Regulations Innate Pharma
PRESS RELEASE

published on 09/02/2025 at 07:00, 10 months 12 days ago

Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Innate Pharma publie le nombre d'actions et de droits de vote au 1er septembre 2025 selon les régulations AMF. Détails du capital social et des droits de vote

Droits De Vote Biotechnologie Actions AMF Innate Pharma
BRIEF

published on 08/04/2025 at 07:05, 11 months 10 days ago

New number of shares and voting rights for Innate Pharma

AMF Financial Update Shares And Voting Rights Commercial Code Innate Pharma
BRIEF

published on 08/04/2025 at 07:05, 11 months 10 days ago

Nouveau nombre d'actions et de droits de vote pour Innate Pharma

Code De Commerce AMF Innate Pharma Actions Et Droits De Vote Actualisation Financière
PRESS RELEASE

published on 08/04/2025 at 07:00, 11 months 10 days ago

Inside Information / Other news releases
Innate Pharma discloses total shares outstanding and voting rights as of August 1, 2025. The company is a global biotech developing immunotherapies for cancer patients

Voting Rights Biotechnology Immunotherapy Innate Pharma Shares Outstanding
PRESS RELEASE

published on 08/04/2025 at 07:00, 11 months 10 days ago

Informations privilégiées / Autres communiqués
Innate Pharma publie son nouveau nombre d'actions et de droits de vote au 1er août 2025 selon les réglementations de l'AMF. Détails ci-dessous

Nombre D'actions Droits De Vote AMF Innate Pharma Biotechnologies
BRIEF

published on 07/04/2025 at 07:05, 1 year ago

Innate Pharma annonce une mise à jour de ses actions et de ses droits de vote

Euronext Actions Nasdaq Droit De Vote Innate Pharma
BRIEF

published on 07/04/2025 at 07:05, 1 year ago

Innate Pharma Announces Share and Voting Rights Update

Voting Rights Shares Euronext Nasdaq Innate Pharma
PRESS RELEASE

published on 07/04/2025 at 07:00, 1 year ago

Inside Information / Other news releases
Innate Pharma discloses number of shares and voting rights as of July 3, 2025, in accordance with French regulations. Total shares: 92,183,523. Total voting rights: 92,962,943 (theoretical) and 92,944,368 (exercisable)

Voting Rights Shares French Regulations Financial Disclosure Innate Pharma
BRIEF

published on 06/17/2025 at 07:05, 1 year ago

Innate Pharma to Participate in Key Investor Conferences

Biotechnology Investor Conferences Healthcare Immunotherapy Innate Pharma

Published on 07/14/2026 at 01:45, 7 hours 41 minutes ago

Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 9 hours 25 minutes ago

Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 10 hours 16 minutes ago

Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 11 hours 51 minutes ago

ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 13 hours 26 minutes ago

IBC Announces Share-Based Compensation to Directors

View all ACCESSWIRE

Published on 07/14/2026 at 09:05, 21 minutes ago

ORTEC acquires TOBA HR Solutions to strengthen healthcare workforce management in Belgium and Luxembourg
Published on 07/14/2026 at 09:05, 21 minutes ago

ASIA'S 50 BEST BARS UNVEILS THE EXTENDED 51-100 LIST FOR 2026
Published on 07/14/2026 at 09:00, 26 minutes ago

Official List Notice
Published on 07/14/2026 at 08:30, 56 minutes ago

RBI on the interim status of acceptances of the voluntary public tender offer for all Addiko shares as of 13 July 2026
Published on 07/14/2026 at 08:00, 1 hour 26 minutes ago

Notice of Interim Results

View all EQS

Published on 07/13/2026 at 18:00, 15 hours 26 minutes ago

CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 15 hours 26 minutes ago

PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 15 hours 26 minutes ago

THERMADOR GROUPE : 2026 half-year turnover
Published on 07/13/2026 at 18:00, 15 hours 26 minutes ago

THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Published on 07/13/2026 at 17:45, 15 hours 41 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News